Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up (Q79355854)
Jump to navigation
Jump to search
scientific article published on 14 November 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up |
scientific article published on 14 November 2006 |
Statements
Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up (English)
Wirth M
Tyrrell C
Delaere K
Sánchez-Chapado M
Ramon J
Wallace DM
Hetherington J
Pina F
Heyns CF
Navani S
14 November 2006